NEWS

News Articles

Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases

July 7, 2020

The collaboration with Numab Therapeutics expands Boehringer Ingelheim’s bi- and multi-specific antibody pipeline with two front-runner projects in lung and gastrointestinal (GI) cancer and geographic atrophy (GA)Numab’s proprietary platform enables the engineering of first-in-class and best-in-class bi- and multi-specific antibodies in a true plug-and-play fashion Boehringer Ingelheim andNumab Therapeutics (Numab) today announced that they have entered…

Read More

Boehringer creates Shanghai hub to connect with Chinese R&D groups

July 6, 2020

Boehringer Ingelheim has opened a site in Shanghai to connect its R&D, business development and venture capital groups to Chinese drug developers. The site brings together all the units involved in the identification and support of promising drug development projects. With China’s domestic biotech scene blossoming, Boehringer has identified the country as a source of programs of…

Read More

Becton Dickinson Wins FDA Approval of 15-Minute, Hand-Held Covid Test

July 6, 2020

Becton Dickinson & Co. won a U.S. regulator’s approval for a portable Covid-19 test that delivers results in 15 minutes. The Food and Drug Administration granted an emergency-use authorization for the BD Veritor Plus System, Franklin Lakes, New Jersey-based Becton Dickinson said Monday in a statement. The hand-held product, which is around the size of a mobile…

Read More

CDC gets FDA nod for coronavirus-flu combination diagnostic

July 6, 2020

Dive Brief: FDA has granted emergency use authorization to a test from the Centers for Disease Control and Prevention designed to determine if a patient is infected with influenza or the novel coronavirus. The agency said Thursday the test will enable healthcare professionals to tell if respiratory symptoms are due to seasonal flu or COVID-19 using a single sample.…

Read More

An Inside-Out Biomedical Discovery

July 2, 2020

Takayama lab develops a better tool for studying cancer, new geometrically-inverted organoids Georgia Institute of Technology researchers are developing new tools of discovery with the creation of inverted ‘organoids’ – three-dimensional, complex, self-organized collections of cells that can recapitulate the processes of a patient’s own tissues. Working with collaborators from the University of Michigan, investigators…

Read More

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2

July 1, 2020

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program, Project Lightspeed, against SARS-CoV-2, the virus causing the current global pandemic. The BNT162 program is evaluating at least four experimental vaccines, each of which represents a unique combination of mRNA…

Read More